Financial insights of NVCR

MyFinsight

For the quarter ending 2025-09-30, NVCR made $167,204K in revenue. -$37,270K in net income. Net profit margin of -22.29%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net revenues	167,204	158,805	154,994	155,095
Cost of revenues	44,729	41,472	38,521	35,372
Gross profit	122,475	117,333	116,473	119,723
Research, development and clinical studies	54,029	55,833	53,777	51,882
Sales and marketing	58,546	57,066	55,792	59,830
General and administrative	45,921	43,955	44,769	40,103
Total operating costs and expenses	158,496	156,854	154,338	151,815
Operating income (loss)	-36,021	-39,521	-37,865	-32,092
Financial income (expenses), net	5,999	4,542	7,570	10,507
Income (loss) before income tax	-30,022	-34,979	-30,295	-21,585
Income tax	7,248	5,160	4,024	8,985
Net income (loss)	-37,270	-40,139	-34,319	-30,570

Basic net income (loss) per ordinary share	-0.33	-0.36	-0.31	-0.28
Diluted net income (loss) per ordinary share	-0.33	-0.36	-0.31	-0.28
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)	111,908,252	111,572,191	110,281,832	108,247,716
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)	111,908,252	111,572,191	110,281,832	108,247,716